Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38


Pten in the breast tumor microenvironment: modeling tumor-stroma coevolution.

Wallace JA, Li F, Leone G, Ostrowski MC.

Cancer Res. 2011 Feb 15;71(4):1203-7. doi: 10.1158/0008-5472.CAN-10-3263. Epub 2011 Feb 8. Review.


Metastatic behavior of breast cancer subtypes.

Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, Nielsen TO, Gelmon K.

J Clin Oncol. 2010 Jul 10;28(20):3271-7. doi: 10.1200/JCO.2009.25.9820. Epub 2010 May 24.


Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast.

Bauer M, Su G, Casper C, He R, Rehrauer W, Friedl A.

Oncogene. 2010 Mar 25;29(12):1732-40. doi: 10.1038/onc.2009.463. Epub 2010 Jan 11.


Degree of tumor FDG uptake correlates with proliferation index in triple negative breast cancer.

Tchou J, Sonnad SS, Bergey MR, Basu S, Tomaszewski J, Alavi A, Schnall M.

Mol Imaging Biol. 2010 Dec;12(6):657-62. doi: 10.1007/s11307-009-0294-0. Epub 2009 Dec 12.


Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.

Santos AM, Jung J, Aziz N, Kissil JL, Puré E.

J Clin Invest. 2009 Dec;119(12):3613-25. doi: 10.1172/JCI38988. Epub 2009 Nov 16.


Pten in stromal fibroblasts suppresses mammary epithelial tumours.

Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A, Creasap N, Thompson JC, Caserta E, Wang H, Chong JL, Naidu S, Wei G, Sharma SM, Stephens JA, Fernandez SA, Gurcan MN, Weinstein MB, Barsky SH, Yee L, Rosol TJ, Stromberg PC, Robinson ML, Pepin F, Hallett M, Park M, Ostrowski MC, Leone G.

Nature. 2009 Oct 22;461(7267):1084-91. doi: 10.1038/nature08486.


Differences in the tumor microenvironment between African-American and European-American breast cancer patients.

Martin DN, Boersma BJ, Yi M, Reimers M, Howe TM, Yfantis HG, Tsai YC, Williams EH, Lee DH, Stephens RM, Weissman AM, Ambs S.

PLoS One. 2009;4(2):e4531. doi: 10.1371/journal.pone.0004531. Epub 2009 Feb 19.


Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast.

Hu M, Peluffo G, Chen H, Gelman R, Schnitt S, Polyak K.

Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3372-7. doi: 10.1073/pnas.0813306106. Epub 2009 Feb 13.


Cancer-associated fibroblasts and tumor growth--bystanders turning into key players.

Ostman A, Augsten M.

Curr Opin Genet Dev. 2009 Feb;19(1):67-73. doi: 10.1016/j.gde.2009.01.003. Epub 2009 Feb 9. Review.


A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer.

Farmer P, Bonnefoi H, Anderle P, Cameron D, Wirapati P, Becette V, André S, Piccart M, Campone M, Brain E, Macgrogan G, Petit T, Jassem J, Bibeau F, Blot E, Bogaerts J, Aguet M, Bergh J, Iggo R, Delorenzi M.

Nat Med. 2009 Jan;15(1):68-74. doi: 10.1038/nm.1908. Epub 2009 Jan 4. Erratum in: Nat Med. 2009 Feb;15(2):220. Wirapati, Pratyakasha [corrected to Wirapati, Pratyaksha].


Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists.

Huang da W, Sherman BT, Lempicki RA.

Nucleic Acids Res. 2009 Jan;37(1):1-13. doi: 10.1093/nar/gkn923. Epub 2008 Nov 25.


Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapy.

Mercier I, Casimiro MC, Wang C, Rosenberg AL, Quong J, Minkeu A, Allen KG, Danilo C, Sotgia F, Bonuccelli G, Jasmin JF, Xu H, Bosco E, Aronow B, Witkiewicz A, Pestell RG, Knudsen ES, Lisanti MP.

Cancer Biol Ther. 2008 Aug;7(8):1212-25. Epub 2008 Aug 30.


Stromal gene expression predicts clinical outcome in breast cancer.

Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A, Hallett M, Park M.

Nat Med. 2008 May;14(5):518-27. doi: 10.1038/nm1764. Epub 2008 Apr 27.


Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.

Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, Bellon JR, Wong JS, Smith BL, Harris JR.

J Clin Oncol. 2008 May 10;26(14):2373-8. doi: 10.1200/JCO.2007.14.4287. Epub 2008 Apr 14. Erratum in: J Clin Oncol. 2008 Jun;26(18):3110.


Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer.

Casey T, Bond J, Tighe S, Hunter T, Lintault L, Patel O, Eneman J, Crocker A, White J, Tessitore J, Stanley M, Harlow S, Weaver D, Muss H, Plaut K.

Breast Cancer Res Treat. 2009 Mar;114(1):47-62. doi: 10.1007/s10549-008-9982-8. Epub 2008 Mar 29.


Microenvironmental regulation of cancer development.

Hu M, Polyak K.

Curr Opin Genet Dev. 2008 Feb;18(1):27-34. doi: 10.1016/j.gde.2007.12.006. Epub 2008 Feb 20. Review.


Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.

Pietras K, Pahler J, Bergers G, Hanahan D.

PLoS Med. 2008 Jan 29;5(1):e19. doi: 10.1371/journal.pmed.0050019.


Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells.

Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K, Sahai E.

Nat Cell Biol. 2007 Dec;9(12):1392-400. Epub 2007 Nov 25.


Heterogeneity of stromal fibroblasts in tumors.

Orimo A, Weinberg RA.

Cancer Biol Ther. 2007 Apr;6(4):618-9. No abstract available.


Differential gene expression profile in breast cancer-derived stromal fibroblasts.

Singer CF, Gschwantler-Kaulich D, Fink-Retter A, Haas C, Hudelist G, Czerwenka K, Kubista E.

Breast Cancer Res Treat. 2008 Jul;110(2):273-81. Epub 2007 Sep 26.


Supplemental Content

Support Center